| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study.
|
Arch Intern Med
|
2009
|
7.82
|
|
2
|
Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices.
|
JAMA
|
2012
|
3.01
|
|
3
|
[Antiretroviral therapy of HIV infection: duration and reasons for changing the first therapeutic regimen in 518 patients].
|
Med Clin (Barc)
|
2006
|
2.14
|
|
4
|
Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count.
|
J Acquir Immune Defic Syndr
|
2004
|
2.11
|
|
5
|
[Costs and cost-efficacy analysis of the preferred treatments by GESIDA/National Plan for AIDS for the initial antiretroviral therapy in adult human immunodeficiency virus (HIV) infected patients in 2012].
|
Enferm Infecc Microbiol Clin
|
2012
|
2.02
|
|
6
|
Prevention of infective endocarditis: between progress in scientific knowledge and the lack of randomized trials.
|
Rev Esp Cardiol (Engl Ed)
|
2012
|
1.99
|
|
7
|
[Spanish cohort of naïve HIV-infected patients (CoRIS): rationale, organization and initial results].
|
Enferm Infecc Microbiol Clin
|
2007
|
1.83
|
|
8
|
Health care-associated native valve endocarditis: importance of non-nosocomial acquisition.
|
Ann Intern Med
|
2009
|
1.76
|
|
9
|
Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone.
|
Ann Intern Med
|
2007
|
1.69
|
|
10
|
The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
|
Liver Transpl
|
2009
|
1.65
|
|
11
|
Surgical treatment of pacemaker and defibrillator lead endocarditis: the impact of electrode lead extraction on outcome.
|
Chest
|
2003
|
1.62
|
|
12
|
Heterogeneous vancomycin-intermediate susceptibility phenotype in bloodstream methicillin-resistant Staphylococcus aureus isolates from an international cohort of patients with infective endocarditis: prevalence, genotype, and clinical significance.
|
J Infect Dis
|
2009
|
1.62
|
|
13
|
Pancreatic toxic effects associated with co-administration of didanosine and tenofovir in HIV-infected adults.
|
Lancet
|
2004
|
1.59
|
|
14
|
Primary human immunodeficiency virus type 1 infection: clinical, virological and immunological characteristics of 75 patients (1997-2003).
|
Enferm Infecc Microbiol Clin
|
2006
|
1.59
|
|
15
|
Pneumocystis jirovecii pneumonia in Spanish HIV-infected patients in the combined antiretroviral therapy era: prevalence of dihydropteroate synthase mutations and prognostic factors of mortality.
|
Diagn Microbiol Infect Dis
|
2008
|
1.58
|
|
16
|
[HIV infection in immigrants in Spain: Epidemiological characteristics and clinical presentation in the CoRIS Cohort (2004-2006)].
|
Enferm Infecc Microbiol Clin
|
2009
|
1.57
|
|
17
|
Epidemiology and outcome of infections in human immunodeficiency virus/hepatitis C virus-coinfected liver transplant recipients: a FIPSE/GESIDA prospective cohort study.
|
Liver Transpl
|
2012
|
1.53
|
|
18
|
[Spanish GESIDA/Nacional AIDS Plan Recommendations for antiretroviral therapy in HIV-infected Adults (October 2004)].
|
Enferm Infecc Microbiol Clin
|
2004
|
1.42
|
|
19
|
Therapeutic immunization with dendritic cells loaded with heat-inactivated autologous HIV-1 in patients with chronic HIV-1 infection.
|
J Infect Dis
|
2005
|
1.32
|
|
20
|
Delayed diagnosis of HIV infection in a multicenter cohort: prevalence, risk factors, response to HAART and impact on mortality.
|
Curr HIV Res
|
2009
|
1.30
|
|
21
|
Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries.
|
Clin Infect Dis
|
2012
|
1.25
|
|
22
|
Daptomycin is effective in treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.
|
Antimicrob Agents Chemother
|
2008
|
1.23
|
|
23
|
Patients at risk of complications of Staphylococcus aureus bloodstream infection.
|
Clin Infect Dis
|
2009
|
1.20
|
|
24
|
A simplification trial switching from nucleoside reverse transcriptase inhibitors to once-daily fixed-dose abacavir/lamivudine or tenofovir/emtricitabine in HIV-1-infected patients with virological suppression.
|
J Acquir Immune Defic Syndr
|
2009
|
1.16
|
|
25
|
Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study.
|
Arch Intern Med
|
2008
|
1.16
|
|
26
|
Daptomycin: the role of high-dose and combination therapy for Gram-positive infections.
|
Int J Antimicrob Agents
|
2013
|
1.15
|
|
27
|
Incidence and predictors of immune reconstitution inflammatory syndrome in a rural area of Mozambique.
|
PLoS One
|
2011
|
1.13
|
|
28
|
[Analysis of costs and cost-effectiveness of preferred GESIDA/National AIDS Plan regimens for initial antiretroviral therapy in human immunodeficiency virus infected adult patients in 2013].
|
Enferm Infecc Microbiol Clin
|
2013
|
1.11
|
|
29
|
Plasma stromal cell-derived factor (SDF)-1 levels, SDF1-3'A genotype, and expression of CXCR4 on T lymphocytes: their impact on resistance to human immunodeficiency virus type 1 infection and its progression.
|
J Infect Dis
|
2002
|
1.11
|
|
30
|
Clinical consensus conference: survey on Gram-positive bloodstream infections with a focus on Staphylococcus aureus.
|
Clin Infect Dis
|
2009
|
1.09
|
|
31
|
Sensitivity and specificity of nested and real-time PCR for the detection of Pneumocystis jiroveci in clinical specimens.
|
Diagn Microbiol Infect Dis
|
2006
|
1.09
|
|
32
|
Patients presenting with AIDS in the HAART era: a collaborative cohort analysis.
|
AIDS
|
2008
|
1.02
|
|
33
|
Central nervous system opportunistic infections in developed countries in the highly active antiretroviral therapy era.
|
J Neurovirol
|
2005
|
1.01
|
|
34
|
Immunoarchitecture of lymphoid tissue in HIV-infection during antiretroviral therapy correlates with viral persistence.
|
Mod Pathol
|
2005
|
0.99
|
|
35
|
Efficacy and safety of outpatient parenteral antibiotic therapy for infective endocarditis: a ten-year prospective study.
|
Enferm Infecc Microbiol Clin
|
2011
|
0.98
|
|
36
|
Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure.
|
JAMA
|
2011
|
0.97
|
|
37
|
Immunologic reconstitution after 1 year of highly active antiretroviral therapy, with or without protease inhibitors.
|
J Acquir Immune Defic Syndr
|
2002
|
0.97
|
|
38
|
Optimal timing and best antiretroviral regimen in treatment-naive HIV-infected individuals with advanced disease.
|
J Acquir Immune Defic Syndr
|
2007
|
0.96
|
|
39
|
Relevance of HIV-1-specific CD4+ helper T-cell responses during structured treatment interruptions in patients with CD4+ T-cell nadir above 400/mm3.
|
J Acquir Immune Defic Syndr
|
2004
|
0.95
|
|
40
|
A cytostatic drug improves control of HIV-1 replication during structured treatment interruptions: a randomized study.
|
AIDS
|
2003
|
0.95
|
|
41
|
Long-term results after cardiac surgery in patients infected with the human immunodeficiency virus type-1 (HIV-1).
|
Eur J Cardiothorac Surg
|
2003
|
0.93
|
|
42
|
Highly active antiretroviral therapy (HAART) modifies the incidence and outcome of visceral leishmaniasis in HIV-infected patients.
|
J Acquir Immune Defic Syndr
|
2002
|
0.90
|
|
43
|
Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational study.
|
Clin Infect Dis
|
2004
|
0.90
|
|
44
|
Inflammatory responses in blood samples of human immunodeficiency virus-infected patients with pulmonary infections.
|
Clin Diagn Lab Immunol
|
2004
|
0.89
|
|
45
|
Preoperative risk stratification in infective endocarditis. Does the EuroSCORE model work? Preliminary results.
|
Eur J Cardiothorac Surg
|
2007
|
0.88
|
|
46
|
Behçet's disease in an HIV-1-infected patient treated with highly active antiretroviral therapy.
|
Isr Med Assoc J
|
2006
|
0.88
|
|
47
|
Association between IL28B gene polymorphisms and plasma HCV-RNA levels in HIV/HCV-co-infected patients.
|
AIDS
|
2011
|
0.87
|
|
48
|
Failure of cetirizine to prevent nevirapine-associated rash: a double-blind placebo-controlled trial for the GESIDA 26/01 Study.
|
J Acquir Immune Defic Syndr
|
2004
|
0.86
|
|
49
|
Candida dubliniensis endophthalmitis in a HIV-infected intravenous drug abuser.
|
Mycoses
|
2011
|
0.86
|
|
50
|
Effect of mycophenolate mofetil on immune response and plasma and lymphatic tissue viral load during and after interruption of highly active antiretroviral therapy for patients with chronic HIV infection: a randomized pilot study.
|
J Acquir Immune Defic Syndr
|
2004
|
0.83
|
|
51
|
Polymorphisms in the interleukin-4 receptor alpha chain gene influence susceptibility to HIV-1 infection and its progression to AIDS.
|
Immunogenetics
|
2005
|
0.82
|
|
52
|
Clinical value of ultradeep HIV-1 genotyping and tropism testing in late presenters with advanced disease.
|
AIDS
|
2015
|
0.82
|
|
53
|
Immune restoration in HIV-positive, antiretroviral-naive patients after 1 year of zidovudine/lamivudine plus nelfinavir or nevirapine.
|
Antivir Ther
|
2004
|
0.81
|
|
54
|
[The Spanish AIDS Study Group and Spanish National AIDS Plan (GESIDA/Secretaría del Plan Nacional sobre el Sida) recommendations for the treatment of tuberculosis in HIV-infected individuals (Updated January 2013)].
|
Enferm Infecc Microbiol Clin
|
2013
|
0.81
|
|
55
|
Cryopreserved mitral homograft in the tricuspid position for infective endocarditis: a valve that can be repaired in the long-term (13 years).
|
J Heart Valve Dis
|
2006
|
0.81
|
|
56
|
Risk factors and management of Gram-positive bacteraemia.
|
Int J Antimicrob Agents
|
2009
|
0.81
|
|
57
|
Management of dyslipidaemia in HIV-infected patients receiving antiretroviral therapy.
|
Antivir Ther
|
2004
|
0.81
|
|
58
|
Risk factors for pericardial effusion in native valve infective endocarditis and its influence on outcome.
|
Am J Cardiol
|
2013
|
0.81
|
|
59
|
[Pharmacokinetics and interactions of raltegravir].
|
Enferm Infecc Microbiol Clin
|
2008
|
0.80
|
|
60
|
Predictors of tonsillar tissue HIV-1 viral burden at baseline and after 1 year of antiretroviral therapy.
|
Antivir Ther
|
2003
|
0.80
|
|
61
|
Immunological and virological factors at baseline may predict response to structured therapy interruption in early stage chronic HIV-1 infection.
|
AIDS
|
2002
|
0.80
|
|
62
|
Staphylococcal postoperative subannular left ventricular false aneurysm.
|
Eur J Cardiothorac Surg
|
2003
|
0.79
|
|
63
|
[Specialized home care for infectious disease. Experience from 1995 to 2002].
|
Enferm Infecc Microbiol Clin
|
2007
|
0.79
|
|
64
|
Incidence of hepatocellular carcinoma in HIV-infected patients with cirrhosis: a prospective study.
|
J Acquir Immune Defic Syndr
|
2014
|
0.79
|
|
65
|
Infection with human retroviruses other than HIV-1: HIV-2, HTLV-1, HTLV-2, HTLV-3 and HTLV-4.
|
Expert Rev Anti Infect Ther
|
2015
|
0.79
|
|
66
|
Restoration of T cell responses to toxoplasma gondii after successful combined antiretroviral therapy in patients with AIDS with previous toxoplasmic encephalitis.
|
Clin Infect Dis
|
2011
|
0.79
|
|
67
|
Executive summary of the GESIDA/National AIDS Plan Consensus Document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2015).
|
Enferm Infecc Microbiol Clin
|
2015
|
0.79
|
|
68
|
Prevalence of dihydropteroate synthase genotypes before and after the introduction of combined antiretroviral therapy and their influence on the outcome of Pneumocystis pneumonia in HIV-1-infected patients.
|
Diagn Microbiol Infect Dis
|
2010
|
0.79
|
|
69
|
Identification of recent HIV-1 infection among newly diagnosed cases in Catalonia, Spain (2006-08).
|
Eur J Public Health
|
2011
|
0.78
|
|
70
|
Q fever endocarditis in Spain. Clinical characteristics and outcome.
|
Enferm Infecc Microbiol Clin
|
2011
|
0.78
|
|
71
|
Consensus document on the management of renal disease in HIV-infected patients.
|
Nefrologia
|
2014
|
0.78
|
|
72
|
[Comparison of three methods to calculate adherence in patients receiving antiretroviral treatment].
|
Enferm Infecc Microbiol Clin
|
2002
|
0.78
|
|
73
|
Urgent pneumococcal urinary antigen, importance in the diagnosis of acquired pneumonia in HIV-1 patients.
|
Eur J Emerg Med
|
2011
|
0.78
|
|
74
|
Characteristics and Outcome of Streptococcus pneumoniae Endocarditis in the XXI Century: A Systematic Review of 111 Cases (2000-2013).
|
Medicine (Baltimore)
|
2015
|
0.78
|
|
75
|
[Mortality and morbidity in HIV-infected patients undergoing coronary artery bypass surgery: a case control study].
|
Rev Esp Cardiol
|
2006
|
0.77
|
|
76
|
Role of echocardiogram in decision making for surgery in endocarditis.
|
Curr Infect Dis Rep
|
2010
|
0.77
|
|
77
|
Long-term clinical follow-up, without antiretroviral therapy, of patients with chronic HIV-1 infection with good virological response to structured treatment interruption.
|
Clin Infect Dis
|
2004
|
0.77
|
|
78
|
Daptomycin compared to standard therapy for the treatment of native valve endocarditis.
|
Enferm Infecc Microbiol Clin
|
2010
|
0.77
|
|
79
|
Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2014).
|
Enferm Infecc Microbiol Clin
|
2014
|
0.76
|
|
80
|
Evaluation of the Roche COBAS® TaqMan® HIV-1 test for quantifying HIV-1 RNA in infected cells and lymphoid tissue.
|
J Virol Methods
|
2011
|
0.76
|
|
81
|
Heart transplantation in HIV-infected patients: more cases in Europe.
|
J Heart Lung Transplant
|
2011
|
0.76
|
|
82
|
[Recommendations of the Spanish AIDS Study Group (GESIDA) and the National Aids Plan (PNS) for antiretroviral treatment in adult patients with human immunodeficiency virus infection in 2002].
|
Enferm Infecc Microbiol Clin
|
2002
|
0.76
|
|
83
|
[Antiretroviral therapy in patients with primary HIV infection (corrected)].
|
Med Clin (Barc)
|
2006
|
0.75
|
|
84
|
[Duplicate publication: Infectious endocarditis by Ochrobactrum anthropi on immunocompetent patient].
|
Enferm Infecc Microbiol Clin
|
2005
|
0.75
|
|
85
|
Community-acquired methicillin-resistant Staphylococcus aureus meningitis complicated by cerebral infarction. Role of antibiotic combination of linezolid plus levofloxacin.
|
Intern Med
|
2010
|
0.75
|
|
86
|
[Antiretroviral treatment in patient with advanced immunosuppression].
|
Med Clin (Barc)
|
2006
|
0.75
|
|
87
|
[Renal transplantation in patients with HIV infection].
|
Enferm Infecc Microbiol Clin
|
2005
|
0.75
|
|
88
|
[Prevalence of Pneumocystis jiroveci dihydropteroate synthase in AIDS patients from Spain].
|
Med Clin (Barc)
|
2005
|
0.75
|
|
89
|
Invited commentary.
|
Ann Thorac Surg
|
2011
|
0.75
|
|
90
|
Ex vivo production of autologous whole inactivated HIV-1 for clinical use in therapeutic vaccines.
|
Vaccine
|
2011
|
0.75
|
|
91
|
[Impact factor of Spanish biomedical journals].
|
Med Clin (Barc)
|
2005
|
0.75
|
|
92
|
[Advances in the diagnosis and treatment of hepatitis C virus infection in patients with and without HIV infection].
|
Enferm Infecc Microbiol Clin
|
2005
|
0.75
|
|
93
|
Evolution of resistance mutations pattern in HIV-1-infected patients during intensification therapy with a boosted protease inhibitor.
|
AIDS
|
2005
|
0.75
|
|
94
|
[Infections associated with prosthetic heart valves, vascular prostheses, and cardiac pacemakers and defibrillators].
|
Enferm Infecc Microbiol Clin
|
2008
|
0.75
|
|
95
|
[Characteristics of hepatitis and influenza antivirals: update 2009].
|
Enferm Infecc Microbiol Clin
|
2010
|
0.75
|
|
96
|
[On the way to shortening tuberculosis treatments: clinical trials of the Unitat d' Investagació en Tuberculosi de Barcelona supported by the Centers for Disease Control and Prevention].
|
Gac Sanit
|
2009
|
0.75
|
|
97
|
[Cryptogenic organizing pneumonia in an HIV-patient with good immunological status].
|
Enferm Infecc Microbiol Clin
|
2008
|
0.75
|
|
98
|
[Prevalence of HIV-1-infection in dialysis units in Spain and potential candidates for renal transplantation: results of a Spanish survey].
|
Enferm Infecc Microbiol Clin
|
2005
|
0.75
|
|
99
|
[Characteristics of antiviral drugs, excluding antiretroviral agents: update 2009].
|
Enferm Infecc Microbiol Clin
|
2010
|
0.75
|
|
100
|
Metabolic and immunological effects of antiretroviral agents in healthy individuals receiving post-exposure prophylaxis.
|
Antivir Ther
|
2002
|
0.75
|
|
101
|
Infective endocarditis in patients with cancer: a consequence of invasive procedures or a harbinger of neoplasm?: A prospective, multicenter cohort.
|
Medicine (Baltimore)
|
2017
|
0.75
|
|
102
|
[2004: Transcendental year for Enfermedades Infecciosas y Microbiología Clínica].
|
Enferm Infecc Microbiol Clin
|
2004
|
0.75
|
|
103
|
Health Care-Associated Infective Endocarditis: a Growing Entity that Can Be Prevented.
|
Curr Infect Dis Rep
|
2014
|
0.75
|
|
104
|
Complications of native and prosthetic valve infective endocarditis: update in 2006.
|
Curr Infect Dis Rep
|
2006
|
0.75
|
|
105
|
[Evaluation of the status of patients with severe infection, criteria for intensive care unit admittance. Spanish Society for Infectious Diseases and Clinical Microbiology. Spanish Society of Intensive and Critical Medicine and Coronary Units].
|
Enferm Infecc Microbiol Clin
|
2009
|
0.75
|
|
106
|
[Liver transplantation in patients with HIV infection].
|
Gastroenterol Hepatol
|
2010
|
0.75
|
|
107
|
[Infectious diseases research].
|
Enferm Infecc Microbiol Clin
|
2008
|
0.75
|
|
108
|
[Toward modernization of the editorial process in Enfermedades Infecciosas y Microbiología Clínica].
|
Enferm Infecc Microbiol Clin
|
2008
|
0.75
|
|
109
|
[Human immunodeficiency virus and Chagas disease coinfection treated successfully with benznidazole and a raltegravir-based antiretroviral regimen: a case report].
|
Med Clin (Barc)
|
2010
|
0.75
|
|
110
|
[Characteristics of antiviral drugs].
|
Enferm Infecc Microbiol Clin
|
2003
|
0.75
|
|
111
|
Management of end-stage liver disease in HIV-infected patients.
|
Curr Opin HIV AIDS
|
2007
|
0.75
|
|
112
|
[Challenges in the antimicrobial treatment of infective endocarditis. Role of daptomycin].
|
Enferm Infecc Microbiol Clin
|
2012
|
0.75
|